Aurinia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,899	1,286	1,291	614	2,966	1,750
Market Cap Growth	60.33%	-0.41%	110.30%	-79.30%	69.42%	-20.79%
Enterprise Value	1,625	1,025	1,047	246	2,688	1,367
Last Close Price	14.40	8.98	8.99	4.32	22.87	13.83
PE Ratio	26.18	223.53	-	-	-	-
Forward PE	17.78	24.06	-	-	-	-
PS Ratio	7.14	5.47	7.36	4.58	65.03	34.93
PB Ratio	5.19	3.41	3.42	1.51	6.19	4.29
P/TBV Ratio	5.25	3.45	3.46	1.54	6.30	4.39
P/FCF Ratio	15.87	29.15	-	-	-	-
P/OCF Ratio	15.81	28.97	-	-	-	-
EV/Sales Ratio	6.11	4.36	5.97	1.84	58.94	27.27
EV/EBITDA Ratio	16.16	32.08	-	-	-	-
EV/EBIT Ratio	20.04	81.91	-	-	-	-
EV/FCF Ratio	13.58	23.25	-	-	-	-
Debt / Equity Ratio	0.21	0.21	0.26	0.02	0.02	0.02
Debt / EBITDA Ratio	0.77	2.42	-	-	-	-
Debt / FCF Ratio	0.65	1.80	-	-	-	-
Net Debt / Equity Ratio	-0.75	-0.74	-0.67	-0.94	-0.95	-0.96
Net Debt / EBITDA Ratio	-2.72	-8.73	3.41	3.51	2.57	3.79
Net Debt / FCF Ratio	-2.28	-6.33	7.40	4.78	2.89	5.16
Asset Turnover	0.49	0.43	0.35	0.26	0.09	0.13
Inventory Turnover	1.26	1.24	1.98	2.30	3.14	-
Quick Ratio	5.02	4.05	4.86	8.76	11.84	12.45
Current Ratio	5.76	4.57	5.50	9.60	12.63	13.11
Return on Equity (ROE)	20.65%	1.52%	-19.92%	-24.46%	-40.81%	-29.07%
Return on Assets (ROA)	9.41%	1.42%	-10.53%	-13.74%	-22.43%	-16.54%
Return on Invested Capital (ROIC)	81.48%	8.65%	-114.84%	-482.28%	-907.37%	-1108.53%
Return on Capital Employed (ROCE)	18.00%	2.80%	-18.20%	-26.20%	-36.00%	-24.20%
Earnings Yield	4.10%	0.45%	-6.04%	-17.62%	-6.10%	-5.87%
FCF Yield	6.30%	3.43%	-2.65%	-13.00%	-5.33%	-4.32%
Buyback Yield / Dilution	1.24%	-2.07%	-0.93%	-9.70%	-9.20%	-27.36%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q